Product and Services Finder
|
|
Drug Delivery - Product Reviews
|
|
BIOCIUS focuses on speeding up drug screeningJeff Kelly, Online Industry EditorFor BIOCIUS, speed is everything. Well, just about everything.
The Wakefield, Mass.-based firm specializes in drug screening and discovery technology and services.
Its RapidFire platform can determine the chemical make-up of a given
compound in a matter of seconds, according to Jennifer Rossi, director
of marketing and corporate communications at BIOCIUS. That’s
significantly faster than using high-pressure liquid chromatography, a more common approach to drug screening, which can take up to 10 minutes, Rossi said ... Read More
|
|
|
More
Drug Delivery
Research Library
|
|
Aptalis Pharmaceutical Technologies
|
Aptalis Pharmaceutical Technologies offers a broad portfolio of oral drug delivery technology platforms, including Taste-Masking, Bioavailability Enhancement, and Customized Drug Release. Together, these flexible technology platforms combined with the company’s licensing, manufacturing, and R & D capabilities enable Aptalis Pharmaceutical Technologies and its partners to produce customized drug ...
|
|
|
Freeman Technology Ltd.
|
Powder characterisation for inhaled drug delivery
By Tim Freeman, Director of Operations, Freeman Technology
Manipulating and controlling powder behaviour is a demanding but essential element of pharmaceutical manufacturing. The development and production of dry powder inhalers (DPIs) exemplifies and highlights the difficulties faced, arguably presenting the industry with its toughest powder ...
|
|
|
Aptalis Pharmaceutical Technologies
|
The need for drug delivery solutions For pharmaceutical companies, the use of drug delivery technologies brings several obvious benefits. For example, there are opportunities to:
• extend patents, protecting key brands from generic competition;
• optimise returns on R&D investment by reformulating existing products and creating effective formulations for promising, but difficult to deliver, ...
|
|
|
TransDermal Technologies, Inc.
|
To date, transdermal delivery has been effective in delivering only a very few drugs due to difculties in moving larger, and chemically non-compatible, molecules across the skin's biologically-active barrier. Drugs with higher melting points, drugs of molecular weight greater than 500 Daltons and drugs requiring pharmacological doses of more than 40 mg in 24 hours can not employ patch- or ...
|
|
|
Aptalis Pharmaceutical Technologies
|
Lack of compliance to dosing regimens is widespread largely due
to complicated regimens (e.g., too many medications, too frequent
dosing) and swallowing difficulties. Eurand’s Diffucaps® technology
enables the development of once-daily controlled-release (CR)
capsules or patient-compliant orally disintegrating tablet formulations
(ODT – CR) comprising immediate-release (IR), ...
|
|
|
|
|
|
|
Make Confident
Buying Decisions
- Search 1,037,293 Products
- Compare Products
- Get Pricing & Information
- Download White Papers
- Network With Other Buyers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
